Abstract
The compounds described herein were designed and synthesized at the Salk Institute for Biological Studies. The chemical synthesis for the specific compounds described in this article can be found in a recently published paper (J. Med. Chem. 55:378-389, 2012). The neuroprotection assays presented in this paper were conducted at the Salk Institute in collaboration with Cedars-Sinai Medical Center under a subcontract to NINDS grant NS060685 (PI Lapchak)
Current Pharmaceutical Design
Title:Corrigendum
Volume: 19 Issue: 3
Author(s): Paul A. Lapchak
Affiliation:
Abstract: The compounds described herein were designed and synthesized at the Salk Institute for Biological Studies. The chemical synthesis for the specific compounds described in this article can be found in a recently published paper (J. Med. Chem. 55:378-389, 2012). The neuroprotection assays presented in this paper were conducted at the Salk Institute in collaboration with Cedars-Sinai Medical Center under a subcontract to NINDS grant NS060685 (PI Lapchak)
Export Options
About this article
Cite this article as:
A. Lapchak Paul, Corrigendum, Current Pharmaceutical Design 2013; 19 (3) . https://dx.doi.org/10.2174/1381612811306030527
DOI https://dx.doi.org/10.2174/1381612811306030527 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
Current Cardiology Reviews Cardiovascular Disease: From Diagnosis to Therapy
Current Medicinal Chemistry Neuroimaging Studies of Acute Effects of THC and CBD in Humans and Animals: a Systematic Review
Current Pharmaceutical Design Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke
Current Neurovascular Research Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke
Current Pharmaceutical Design Renin Angiotensin System Gene Polymorphisms in Response to Antihypertensive Drugs and Visit-To-Visit Blood Pressure Variability in Essential Hypertensive Patients
Current Pharmacogenomics and Personalized Medicine Pathophysiology of Coronary Collaterals
Current Cardiology Reviews Multiple Modes of A-Type Potassium Current Regulation
Current Pharmaceutical Design Heat Shock Proteins Protect Against Ischemia and Inflammation Through Multiple Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability
CNS & Neurological Disorders - Drug Targets Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
Current Neuropharmacology Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub> and α<sub>1</sub>-Adrenergic Receptors
CNS & Neurological Disorders - Drug Targets Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Effects of Hyperlipidemia and Cardiovascular Diseases on Proliferation, Differentiation and Homing of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease
Current Alzheimer Research Antidiabetic Drugs as Antihypertensives: New Data on the Horizon
Current Vascular Pharmacology Approach to the Patient with Subclinical Cushing’s Syndrome
Current Pharmaceutical Design Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) The Effect of Sc on the Microstructure and Mechanical Properties of Hypereutectic Al-Si Alloy Fabricated by a Gas Atomization Process
Current Nanoscience